Eli Lilly has announced a significant investment of approximately $27 billion in U.S. manufacturing, marking the largest pharmaceutical manufacturing investment in the country’s history. This expansion includes the construction of four new sites aimed at enhancing medicine production and strengthening the supply chain, with the potential to create nearly 10,000 construction jobs and over 3,000 positions for skilled workers. The initiative demonstrates Lilly’s commitment to meeting the demand for high-quality, FDA-approved medicines and reinforcing domestic manufacturing. Locations for the new sites will be revealed later this year, adding to the company’s previous $23 billion investment in domestic expansion since 2020.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.wfyi.org/wfyi-news/2025-02-27/indy-based-pharmaceutical-giant-eli-lilly-to-invest-roughly-27-billion-in-manufacturing
